-
October 07, 2026
A photographer has maintained that Fairfax & Favor deliberately flouted his copyright by using his images after its license expired, while rejecting the brand's claim that showcasing them in his online portfolio infringed its trademarks.
-
October 07, 2026
Lush has failed to hold onto its name as a trademark for pharmaceutical products, after the company failed to provide evidence it had used it commercially in the last five years.
-
October 07, 2026
Abbott has admitted in a London court that a Chinese rival's competing glucose monitor may not infringe its patents, yielding ground to its opponent in a lengthy dispute over their tech for diabetes patients.
-
October 07, 2026
OnlyFans is facing a group claim in England over "exploitative" arrangements involving third-party managers who routinely deprive content creators of their earnings, the company leading the case said on Wednesday.
-
October 07, 2026
Takeda has fought back against Samsung's bid to nix two patents covering its Entyvio-branded drug for Crohn's disease, arguing that the rival was infringing its rights with plans to commercialize biosimilar versions.
-
October 06, 2026
A specialist Aston Martin dealership has denied selling an allegedly fake sports car to a collector for £880,000 ($1.2 million), telling a London court that it had every reason to believe that the vehicle was real.
-
October 06, 2026
The company behind Roblox has accused a food manufacturer of taking unfair advantage of its reputation by selling "Rocblox" candy in the U.K., which allegedly evokes the popular gaming platform's blocky avatars and pixelated aesthetic.
-
October 06, 2026
French fashion house Celine has persuaded European officials to block a retailer from registering "Cēlyn" as a trademark, showing that shoppers would likely confuse the two brands when buying makeup and other cosmetic products.
-
October 06, 2026
A Dutch court has prohibited a supplier from continuing to sell counterfeit Labubu dolls to a local supermarket chain, finding that it was infringing on Chinese toymaker Pop Mart's trademarks for the monster toys.
-
October 06, 2026
Italian Prime Minister Giorgia Meloni has filed for a European Union trademark over her voice in a move potentially designed to combat the risk of artificial intelligence deepfakes.
-
October 05, 2026
Jones Day has brought on an Arnold & Porter Kaye Scholer LLP partner and NautaDutilh's former technology group leader as partners in its intellectual property practice, the firm told Law360.
-
October 05, 2026
The U.K.'s Intellectual Property Office has denied AI company Emotional Perception's patent application for an artificial neural network, despite winning a landmark U.K. Supreme Court decision that similar AI inventions should not be denied patent protections by default.
-
October 05, 2026
Counsel for generic drugmaker Dr. Reddy's urged a London court Monday to invalidate patent protections for Boehringer Ingelheim's billion-dollar diabetes treatment, in a bid to clear the way for its own generic version.
-
October 05, 2026
A British vendor for Costco has sued a Dutch supplier and the Home Office, accusing the company of approving a fried chicken shipment then falsely reporting copyright infringement to get border officials to detain it.
-
October 05, 2026
A generic drugmaker has accused a rival of misusing its confidential information about insomnia treatment melatonin, asking a London court to block its opponent from using the information to market a competing version of the drug.
-
October 05, 2026
The European Union has refused a British film production company's quest for a trademark over its "Kick-Ass" film title, ruling that the "slang" term isn't capable of distinguishing one company's goods from another.
-
October 02, 2026
German pharmaceutical giant Boehringer will face off against Indian generic drugmaker Dr. Reddy's on Monday in a trial that intellectual property experts hope will shine light on the unsettled question of nonpatented uses for generic drugs.
-
October 02, 2026
An appellate court ruled on Friday that English law should determine whether a previous Georgian decision finding copyright infringement can stop an online game maker from relitigating certain issues in a related U.K. dispute.
-
October 02, 2026
InterDigital and tech licensor Avanci have pushed back against Tesla's claim that they failed to offer fair licensing terms for 5G patents for use in its electric cars, arguing that the automaker wasn't entitled to a license covering the whole patent pool.
-
October 02, 2026
IP Group said Friday that it has sold a part of its stake in Oxford Nanopore and raised £21 million ($27.8 million) to strengthen its financial position and provide capital for investments elsewhere in its portfolio and other group priorities.
-
October 02, 2026
French media giant Canal Plus has partially convinced European officials that a financial consultancy firm's trademark for "CubeMatch" has too much in common with its earlier sign for "+Le Cube."
-
October 02, 2026
The past week in London has seen former West Ham United co-chair David Sullivan file a defamation claim against the BBC, British rock band Oasis sue its former sound engineer to halt an auction of recordings, and Home REIT sued by its shareholders for misleading statements about the company's portfolio.
-
October 02, 2026
Marshall Group AB told a London court on Friday that a rival retailer infringed its trademarks by selling counterfeit headphones on Amazon.
-
October 01, 2026
A New York federal judge has denied Novartis' bid to toss an investment management firm's lawsuit accusing the pharmaceutical company and others of helping the firm's former chief investment officer steal confidential investment strategies to launch a rival hedge fund, saying the firm's trade secret claims had enough detail to withstand dismissal.
-
October 01, 2026
The presiding judge at the German Federal Court of Justice said Thursday that after three years the Unified Patent Court has successfully integrated into Europe's fractured patent system, quelling concerns that yet another player might lead to wildly different approaches to major patent issues.